Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Policies On Boosting China’s Bioindustry To Be Out This Year

This article was originally published in PharmAsia News

Executive Summary

China's National Development and Reform Commission will progressively issue a series of implementation regulations on policies to boost local bioindustry development. It aims to accomplish the following four tasks in the short term: (1) speed up improvement of taxation policies and financing for the bioindustry to foster the biotechnology market; (2) enhance the industry's capability of independent innovation and promote bioenterprise cluster development; (3) continue to organize the implementation of major special projects for the industry; and (4) have the national expert consultation committee fully execute its function of developing the bioindustry to prepare for the 12th five-year plan. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072112

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel